Johns Hopkins Diabetes GuideBrand Names

Orlistat

Alona Crowder, Pharm.D., Reza Alavi, M.D.
Orlistat is a topic covered in the Johns Hopkins Diabetes Guide.

To view the entire topic, please or purchase a subscription.

Johns Hopkins Guides provide diagnosis, management, and treatment guidance for infectious diseases, diabetes, and psychiatric conditions. Explore these free sample topics:

Johns Hopkins Guides

~~ The first section of this topic is shown below ~~

INDICATIONS

FDA

  • Xenical (Prescription Strength): Obesity management including weight loss and weight maintenance in patients with a body mass index (BMI) ≥ 30 kg/m2 OR ≥ 27 kg/m2 in the presence of other risk factors (eg, hypertension, diabetes, dyslipidemia).
  • Alli (OTC Strength): Obesity management in overweight adults (18 years and older) when used along with a reduced-calorie and low-fat diet

~~ To view the remaining sections of this topic, please
or purchase a subscription ~~

Last updated: November 30, 2015